These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1047 related items for PubMed ID: 16909118
41. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2. Xu R, Chen J, Cong X, Hu S, Chen X. J Cell Biochem; 2008 Jan 01; 103(1):256-69. PubMed ID: 17497701 [Abstract] [Full Text] [Related]
42. Albumin activates ERK via EGF receptor in human renal epithelial cells. Reich H, Tritchler D, Herzenberg AM, Kassiri Z, Zhou X, Gao W, Scholey JW. J Am Soc Nephrol; 2005 May 01; 16(5):1266-78. PubMed ID: 15829704 [Abstract] [Full Text] [Related]
43. MAP kinase: it's been longer than fifteen minutes. Sturgill TW. Biochem Biophys Res Commun; 2008 Jun 20; 371(1):1-4. PubMed ID: 18406346 [Abstract] [Full Text] [Related]
44. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation. Fushimi K, Nakashima S, You F, Takigawa M, Shimizu K. J Cell Biochem; 2007 Feb 15; 100(3):783-93. PubMed ID: 17031853 [Abstract] [Full Text] [Related]
45. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells. Wang Z, Yang H, Tachado SD, Capó-Aponte JE, Bildin VN, Koziel H, Reinach PS. Invest Ophthalmol Vis Sci; 2006 Dec 15; 47(12):5267-75. PubMed ID: 17122112 [Abstract] [Full Text] [Related]
46. Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK1/2. Moniz S, Veríssimo F, Matos P, Brazão R, Silva E, Kotelevets L, Chastre E, Gespach C, Jordan P. Oncogene; 2007 Sep 06; 26(41):6071-81. PubMed ID: 17667937 [Abstract] [Full Text] [Related]
47. Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis. Jiang CC, Chen LH, Gillespie S, Wang YF, Kiejda KA, Zhang XD, Hersey P. Cancer Res; 2007 Oct 15; 67(20):9750-61. PubMed ID: 17942905 [Abstract] [Full Text] [Related]
48. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells. Bessard A, Frémin C, Ezan F, Coutant A, Baffet G. J Cell Physiol; 2007 Aug 15; 212(2):526-36. PubMed ID: 17427199 [Abstract] [Full Text] [Related]
58. Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase. Turner SD, Tooze R, Maclennan K, Alexander DR. Oncogene; 2003 Oct 30; 22(49):7750-61. PubMed ID: 14586401 [Abstract] [Full Text] [Related]
59. Role of Rad51 down-regulation and extracellular signal-regulated kinases 1 and 2 inactivation in emodin and mitomycin C-induced synergistic cytotoxicity in human non-small-cell lung cancer cells. Su YJ, Tsai MS, Kuo YH, Chiu YF, Cheng CM, Lin ST, Lin YW. Mol Pharmacol; 2010 Apr 30; 77(4):633-43. PubMed ID: 20042515 [Abstract] [Full Text] [Related]
60. Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244. Ammoun S, Ristic N, Matthies C, Hilton DA, Hanemann CO. Neurobiol Dis; 2010 Jan 30; 37(1):141-6. PubMed ID: 19804833 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]